Search

Search Constraints

You searched for: Author/Creator Friedrichsen, Karl A.

Search Results

1. [IC‐P‐057]: CLINICAL RISK RELATED TO CEREBRAL MICROHEMORRHAGES IN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE: LONGITUDINAL RESULTS FROM THE DIAN STUDY. (1st July 2017)

2. [IC‐P‐166]: UTILITY OF PERFUSION PET MODELS AS MEASURE OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

3. [O1–02–04]: CLINICAL RISK RELATED TO CEREBRAL MICROHEMORRHAGES IN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE: LONGITUDINAL RESULTS FROM THE DIAN STUDY. (1st July 2017)

4. [P2–372]: UTILITY OF PERFUSION PET MODELS AS MEASURES OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

5. IC‐01‐03: Classifying TAU Pet Positivity With [18F]‐AV‐1451 in Preclinical Alzheimer's Disease. (1st July 2016)

6. IC‐03‐02: Early frame of PiB and FDG in autosomal dominant Alzheimer's disease: Similarity, discrepancy, and clinical implication. (1st July 2015)

7. IC‐P‐051: Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence. (1st July 2015)

8. IC‐P‐052: Comparison of cerebral glucose metabolism 18F‐FDG, early frames of 11C‐PIB,  and cerebral blood flow 15O‐H2O in autosomal dominant Alzheimer's disease. (1st July 2015)

9. IC‐P‐100: The ILP: A new tool for evaluating preclinical Alzheimer's disease using volumetric MRI in a single participant. (1st July 2015)

10. IC‐P‐117: Neuronal Injury and Degeneration Evaluated With Imaging and CSF Biomarkers in Autosomal Dominant AD: Results From The Dian Study. (1st July 2016)